“Mad Money” host offers stock insights in rapid-fire lightning round #

• Marvell Technology: “Mixed quarter, wait.”
• Datadog: “Dynamite company, a buy despite high cost.”
• Centrus Energy: “Speculative situation, consider diversified GE spinoff Vernova.”
• Altimmune: “High-risk stock, consider Eli Lilly instead.”
• Lantheus: “Prefer RadNet for better business model.”
• SoFi: “Convertible bond issue hurt stock, uncertain outlook.”
• On Holding: “Controversial quarter, undecided.”

“Mad Money” host Jim Cramer recently provided rapid-fire answers to callers’ stock questions during the lightning round. Cramer advised waiting on Marvell Technology due to a mixed quarter. He expressed enthusiasm for Datadog, praising it as a dynamite company despite its high price. Cramer recommended considering the GE spinoff Vernova for diversified exposure to nuke energy in the Centrus Energy situation. He classified Altimmune as a high-risk stock and suggested considering Eli Lilly instead. Cramer shared his preference for RadNet over Lantheus due to its stronger business model. He expressed concerns about SoFi following a convertible bond issue that negatively impacted the stock. Cramer was undecided on On Holding, describing its recent quarter as controversial.